Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a frontrunner in the medical technology industry, has announced its participation in Piper Sandler’s 35th Annual Healthcare Conference. The commercial-stage company is …
TELA Bio to Showcase Innovations at Piper Sandler’s 35th Annual Healthcare Conference Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, has recently announced the approval of inducement grants by its Compensation Committee. The grants, which cover 40,700 …
TELA Bio Announces Inducement Grants for Newly-Hired Employees Under Nasdaq Rule Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading player in the biotechnology industry, recently reported its financial results for the third quarter of 2023, marking an impressive 11th …
TELA Bio Reports Q3 2023 Results: 11th Consecutive Quarter of 35% YoY Growth Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that the Company will report third quarter 2023 financial results on Thursday, November 9, 2023. TELA Bio’s management will host a …
TELA Bio to Announce Third Quarter 2023 Financial Results Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, recenlty announced the launch of their OviTex PRS Long-Term Resorbable product. OviTex PRS Long-Term Resorbable is intended …
TELA Bio Unveils Groundbreaking OviTex PRS: Revolutionizing Plastic and Reconstructive Surgery Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) this week reported financial results for the second quarter ended June 30, 2023.
TELA Bio Reports Second Quarter 2023 Financial Results Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, recently announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants …
TELA Bio Grants Restricted Stock Units to Newly-Hired Employees Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, announced that the Company will report second quarter 2023 financial results on Wednesday, August 9, 2023. TELA …
TELA Bio to Announce Second Quarter 2023 Financial Results Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced results from a consumer survey on consumer awareness, preferences, and doctor expectations regarding hernia repair options.
New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that the Company will participate in the Jefferies Global Healthcare Conference on Wednesday, June 7th, 2023.
TELA Bio to Participate in the Jefferies Global Healthcare Conference Read More